169 related articles for article (PubMed ID: 38268018)
21. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
[TBL] [Abstract][Full Text] [Related]
22. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients.
Kohrt HE; Olshen RA; Bermas HR; Goodson WH; Wood DJ; Henry S; Rouse RV; Bailey L; Philben VJ; Dirbas FM; Dunn JJ; Johnson DL; Wapnir IL; Carlson RW; Stockdale FE; Hansen NM; Jeffrey SS;
BMC Cancer; 2008 Mar; 8():66. PubMed ID: 18315887
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
24. Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients.
Maimaitiaili A; Wu D; Liu Z; Liu H; Muyiduli X; Fan Z
Cancer Biol Med; 2018 Aug; 15(3):282-289. PubMed ID: 30197795
[TBL] [Abstract][Full Text] [Related]
25. Predictors to assess non-sentinel lymph node status in breast cancer patients with only one sentinel lymph node metastasis.
Yang B; Yang L; Zuo WS; Ge WK; Zheng G; Zheng MZ; Yu ZY; Wang YS
Chin Med J (Engl); 2013 Feb; 126(3):476-81. PubMed ID: 23422110
[TBL] [Abstract][Full Text] [Related]
26. Sentinel Lymph Node Positive Rate Predicts Non-Sentinel Lymph Node Metastasis in Breast Cancer.
Wang X; Zhang G; Zuo Z; Zhu Q; Wu S; Zhou Y; Mao F; Lin Y; Shen S; Zhang X; Qin X; Yan C; Ma X; Shi Y; Sun Q
J Surg Res; 2022 Mar; 271():59-66. PubMed ID: 34839110
[TBL] [Abstract][Full Text] [Related]
27. [Value of sentinel lymph node metastasis status in predicting the presence of residual disease in the non-sentinel lymph node of breast cancer patients].
Yang B; Yang L; Zuo WS; Ge WK; Wang YS; Zheng G; Zheng MZ; Yu ZY
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(14):1072-5. PubMed ID: 23902839
[TBL] [Abstract][Full Text] [Related]
28. Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.
Barron AU; Hoskin TL; Boughey JC
Ann Surg Oncol; 2018 Oct; 25(10):2867-2874. PubMed ID: 29956095
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
[TBL] [Abstract][Full Text] [Related]
30. Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.
Sa-Nguanraksa D; O-Charoenrat E; Kulprom A; Samarnthai N; Lohsiriwat V; Nimpoonsri K; O-Charoenrat P
Breast Cancer; 2019 Jul; 26(4):471-477. PubMed ID: 30617675
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of sentinel node metastatic burden and Her-2/neu over-expression accurately predicts residual axillary nodal involvement and extranodal disease in breast cancer.
Chae AW; Vandewalker KM; Li YJ; Beckett LA; Ramsamooj R; Bold RJ; Khatri VP
Eur J Surg Oncol; 2013 Jun; 39(6):627-33. PubMed ID: 23523315
[TBL] [Abstract][Full Text] [Related]
32. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
[TBL] [Abstract][Full Text] [Related]
33. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
34. Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis.
Jeeravongpanich P; Chuangsuwanich T; Komoltri C; Ratanawichitrasin A
Gland Surg; 2014 Feb; 3(1):2-13. PubMed ID: 25083488
[TBL] [Abstract][Full Text] [Related]
35. Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal.
Cebrecos I; Mension E; Alonso I; Castillo H; Sanfeliu E; Vidal-Sicart S; Ganau S; Vidal M; Schettini F
Ann Surg Oncol; 2023 Aug; 30(8):4657-4668. PubMed ID: 36809608
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a pre- and intra-operative scoring system that distinguishes between non-advanced and advanced axillary lymph node metastasis in breast cancer with positive sentinel lymph nodes: a retrospective study.
Murata T; Watase C; Shiino S; Kurita A; Ogawa A; Jimbo K; Iwamoto E; Yoshida M; Takayama S; Suto A
World J Surg Oncol; 2022 Sep; 20(1):314. PubMed ID: 36171615
[TBL] [Abstract][Full Text] [Related]
37. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Non-sentinel Lymph Node Metastases After Positive Sentinel Lymph Nodes Using Nomograms.
Gruber I; Henzel M; Schönfisch B; Stäbler A; Taran FA; Hahn M; Röhm C; Helms G; Oberlechner E; Wiesinger B; Nikolaou K; LA Fougère C; Wallwiener D; Hartkopf A; Krawczyk N; Fehm T; Brucker S
Anticancer Res; 2018 Jul; 38(7):4047-4056. PubMed ID: 29970530
[TBL] [Abstract][Full Text] [Related]
39. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
